Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma [Phase 4]
A Phase 4 trial update on icotinib as first-line and maintenance therapy for patients with EGFR-mutated non-small cell lung cancer (lung ade…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA
A completed clinical trial update reports on detecting EGFR delEx19 and KRAS exon 2 mutations in EBUS-TBNA samples from patients with metast…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma [NA]
This clinical trial update discusses applying circulating tumor cell detection to tailor treatment in patients with early-stage lung adenoca…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A+C in Metastatic Lung Adenocarcinoma Cancer [Phase 2]
Phase 2 clinical trial update on a combination therapy for metastatic lung adenocarcinoma. The current status is listed as UNKNOWN in the pr…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Metformin in Stage IV Lung Adenocarcinoma [Phase 2]
A Phase 2 trial of metformin in stage IV non-small cell lung cancer (lung adenocarcinoma) has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, carboplatin, and bevacizumab with or without Cixutumumab in stage IV or recurrent non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma [Phase 1]
This is a completed Phase 1 safety and pharmacology study of SNX-5422 in subjects with resistant lung adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) [Phase 1]
Phase 1 trial update evaluating EC17, a folate-fluorescein imaging agent, for intraoperative visualization of lung cancer; the study has com…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma [Phase 2]
A Phase 2 study of poziotinib as first-line monotherapy for lung adenocarcinoma (Stage IIIB/Stage IV) was terminated; the update does not re…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations [Phase 4]
Phase 4 study results reported for erlotinib (Tarceva) as first-line therapy in patients with locally advanced or metastatic EGFR-mutant non…
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma [Phase 3]
This is a Phase 3 trial update evaluating pemetrexed combined with gefitinib as adjuvant therapy for EGFR-mutant lung adenocarcinoma. The tr…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating cetuximab in lung adenocarcinoma patients who developed acquired resistance to erlotinib; the study is…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma [Phase 4]
This document provides an update on a Phase 4 clinical trial of erlotinib plus pemetrexed as maintenance therapy for Lung Adenocarcinoma. Th…
-
CLINICAL_TRIALS trial_result · 2015-02-27Clinical Trial Update: Study of Vintafolide (MK-8109, EC145) in Participants With Progressive Adenocarcinoma of the Lung (MK-8109-008, EC-FV-03) [Phase 2]
Phase 2 clinical trial of vintafolide (EC145/MK-8109) in patients with progressive lung adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and pemetrexed for lung adenocarcinoma with brain metastases has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma [Phase 2]
This update reports the completion of a Phase 2 trial evaluating neoadjuvant pemetrexed, carboplatin, and bevacizumab in patients with unres…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases [Phase 2]
An update on a Phase 2 clinical trial evaluating high-dose pemetrexed for brain metastases from lung adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis [NA]
A clinical trial evaluating the efficacy of whole brain radiation therapy in lung cancer patients with brain metastases has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion [Phase 3]
Phase 3 trial comparing cVATS segmentectomy versus lobectomy for early-stage lung adenocarcinoma, including adenocarcinoma in situ and micro…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung [Phase 2]
Phase 2 study comparing AXL1717 to docetaxel in non-small cell lung cancer has completed, including lung squamous cell carcinoma and lung ad…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] [Phase 2]
Phase II trial evaluating afatinib (BIBW 2992) as third-line therapy for patients with stage IIIB/IV non-small cell lung cancer with wild-ty…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma
This is an observational study update sponsored by AstraZeneca on the management of patients with non-small cell lung cancer (adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2012-06-20Clinical Trial Update: Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers [Phase 2]
Phase 2 trial evaluating intercalated PamCis with Gefitinib or with placebo as first-line therapy for never-smoker patients with non-small c…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. [Phase 2]
Phase 2 study evaluating axitinib or bevacizumab in combination with paclitaxel and carboplatin for advanced non-small cell lung cancer; the…
-
CLINICAL_TRIALS trial_result · 2010-10-25Clinical Trial Update: First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker [Phase 3]
A Phase 3 trial comparing first-line Gefitinib versus chemotherapy in never-smokers with lung adenocarcinoma has completed.